Academic Journal

Allogeneic Hematopoietic Stem Cell

التفاصيل البيبلوغرافية
العنوان: Allogeneic Hematopoietic Stem Cell
المؤلفون: Transplantation In Patients, Rafael De, La Cámara, Arancha Alonso, Juan Luis Steegmann, Reyes Arranz, Enrique Granados, Gabriela Rodríguez-macías, Cesar Sanz-rodríguez, Valle Gómez, De Soria, Angela Figuera
المساهمون: The Pennsylvania State University CiteSeerX Archives
المصدر: http://www.haematologica.org/full/pdf/2002_09/87965.pdf.
سنة النشر: 2002
المجموعة: CiteSeerX
الوصف: y different between the elderly and young groups: 51% vs. 55% for all patients; 87% vs. 69% in chronic myeloid leukemia; 79% vs. 62% in standard risk patients and 13% vs. 31% in high risk ones. In multivariate analyses no significant difference in overall survival was found between age groups. Interpretation and Conclusions. According to our experience, age alone (between 50-59), should not be considered a contraindication to a conventional HLA identical sibling transplant. 2002, Ferrata Storti Foundation Key words: allogeneic stem cell transplantation; age; elderly; HLA identical sibling; myeloablative conditioning regimen. T he median age of the patients who receive a stem cell transplantation (SCT) is between 25 and 30 years. 1,2 Nonetheless the majority of patients with hematologic malignancies have a median age well over 50 at diagnosis. Thus, for chronic myeloid leukemia (CML), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), lymphoma and myeloma
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: English
Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.7.6929; http://www.haematologica.org/full/pdf/2002_09/87965.pdf
الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.7.6929
http://www.haematologica.org/full/pdf/2002_09/87965.pdf
Rights: Metadata may be used without restrictions as long as the oai identifier remains attached to it.
رقم الانضمام: edsbas.27F786E9
قاعدة البيانات: BASE